From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: MyHealthChecked & Zoetic again, on the latter big questions raised

By Tom Winnifrith | Saturday 31 July 2021


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


On MyHeathChecked (MHC) I tidy up all the loose ends from yesterday’s options storm and I am confident that the greedy management have behaved in this way as the shares will head higher. On the fraud Zoetic (ZOE) I discuss the purchase of the domain name Chill.com and all the questions that throws up. I do know a bit about buying domain names and this is not what it seems. Then I cover the 2 questions that its financial adviser Nick Harriss at Allenby and its scumbag PR Henry Harrison Topham will not respond to and which I will be taking up with the FCA tomorrow. It strikes me these are slam dunk rule breaches. Nick, at least, used to care about such matters.

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

Time left: 10:18:49